Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...
Hosted on MSN1mon
Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContinIt's among the largest settlements reached over the past several years in a series of lawsuits seeking to hold companies responsible for a deadly epidemic. (Scripps News) Judge denies request to ...
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.
The U.S. Supreme Court is hearing many important cases this term, but perhaps none are as consequential — or controversial — as one involving Purdue Pharma. The long-maligned pharmaceutical ...
The move is part of a tentative settlement of $12 billion to settle myriad lawsuits connected to the company’s marketing of opioid painkillers. (JTA) — The Sackler family-owned Purdue Pharma ...
Purdue Pharma, manufacturer of the highly addictive pain killer oxycontin, declared bankruptcy in 2019 and entered into a multibillion dollar settlement over their sales practices with the ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...
Purdue Pharma pleaded guilty Tuesday to federal criminal charges related to the OxyContin manufacturer’s role in the nation’s deadly opioid crisis. (CN) — Purdue Pharma pleaded guilty Tuesday to ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results